Premaitha Share Discussion Threads

[ngen yap] 02/8/2016 13:35

I think the AIM rules states that you release RNS that are share price sensitive. Having announced contract wins and distribution deals previously, and share price not reacting, and clients being sued instead, I reckon management have taken a pragmatic approach in RNS being issued on every tender / deal won. They are clearly winning and more clinics / labs / health institutions are offering IONA (even in places where competitor offering are still on the list). This is being made public in their website.

Interesting win on the Bath Hospital. Thanks for info Dave444 - I don't think it equates to 262 tests. The per test price may be between £250 - £350, but I imagine Premaitha may sell it to customers at say £100 - £150 to allow them to make a margin off it. And where it is a distribution deal eg Genoma, take a cut off their sales. So that's works out closer to 436 - 655 tests, which makes sense for start.....

If we are doing that and more across our 42 units (and growing), we are doing well.

Guess the proof in the pudding will be business results update in due course. Let's see.......

[spoll] 02/8/2016 11:18

dave444 no worries I've just found the confirmation link.

[spoll] 02/8/2016 11:12

dave444 I can see a link to the tender but not who won it - do you have a link?

[the prophet] 02/8/2016 11:09

tend to agree with BlackSS, one to stick in the bottom draw and see what happens once the litigation is out the way.

[dave444] 02/8/2016 11:05

It works out at 262 tests

[the monkster] 02/8/2016 10:59

lol. probably a loss leader.

[dave444] 02/8/2016 10:06

They have just won the Bath Hospital tender for £65,500

[blackss] 02/8/2016 09:40

Lets face it, news has dried up. As Twix says they are obliged to RNS anything of value so the bottom line is we don't have a bloody clue what is going on but we have to assume not a lot. Its typical AIM, all hype and great future when they start out or want to raise some cash but eventually it reverts to Fu"k all as usual. even Winniethrith cant screw punters for a few pence more with this one so we wait till the court case or sell up. This is not worth watching on a daily basis now, stick it in the bottom draw and forget about it for 6 months

[twix386] 02/8/2016 07:56

says the guy (DC) who sold out without a word and just told us he'd bought back in when the risk/reward had improved i.e. the share price had sunk even further!

Look, I do expect sales numbers to be good. That they once would have been expected much better is I suppose spilt milk now. However, the key is the time we have been in the market versus the share price which is the arbiter of visible and material progress. To be sat at the float price or below for thislong and at this stage just makes it unacceptable to call this anything less than dismal to date.

Try answering some of the questions DC.
Why no international news outside EU - other than perhaps Vietnam via website - and why not RNS this news if it's worthy of mention and free from Illumina scope?
Nothing material delivered anywhere this financial years because if so, it must be RNS'd?
and with a year's delay to writ and no contracts/not being reported (RNS), the BOD have created the unfolding share price saga themselves. What other outcome can there be to no visible progress and increasing timeframes whilst under a writ?

You gave up and sold out DC and have a nerve after buying back lower to preach about any loss of faith or comment based on lack of newsflow and share price levels once unimagineable lasting months and on-going! Even our 20p target is a mere shadow of the promise I refered to.

I actually expect we are doing okay, but it's difficult to know isn't it and a snapshot(share price) this last quarter and for sometime I would expect (pre-writ) and with certain questions remaining isn't a good or transparent backdrop.

[dire cons] 02/8/2016 07:22

Now now Ngen, you should know by now that just a mere sniff of positivity will invite an essay of doom from the deramper in chief, The Delivery Boy.

[twix386] 02/8/2016 03:40

Bionet have no mention of us anywhere. They do mention and push and link to Natera's Panorama NIPT test.

imv you are over estimating everything again including the numbers game and as we know any material contract win/news that is market sensitive MUST be rns'd.
Why with Vietnam, can we not mention it when out of illumina's reach?

By Sept we will have had 6 months of commercial contract silence at this rate! The whole financial year to date and what's that done for the share price and sentiment!
It's not rocket science to forecast that when the decision was taken to delay the court hearing by a year and to also go Radio Silent, Then the share price was going to crater. This has been a price we have in part inflicted on ourselves as a price worth paying, but it was a silent plan we got to learn of as it unfolded over months and the share price sank, whilst all we were told was the delay was welcomed to increase our commercial momentum!

Meanwhile there has been no material news as they must RNS anything market sensitive and frankly SL's said a lot about promise, yet so far delivered a lot less than promised!!

[ngen yap] 01/8/2016 23:06

I know we are all starved of news - but in the meantime, and I think someone pointed out earlier, we have more centres / clinics / labs offering IONA - latest in Premaitha website says 42, which continues to grow. Intriguingly, the latest addtion (outside of UK) is in Vietnam with Bionet.vn.

I reference the recent report that St Georges are doing circa 3,700 tests per annum ie their capacity and they want to double that due to demands. We have 42 direct centres / clinics / labs - probably not all the same size as St Georges but even assuming 1,500 tests per centre per year, that is quite a number! This excludes Genoma, France, Greece, Russia and Middle East lab distribution deals. I am sure you can do your own maths, using your own assumptions.

So long no nasties, we are growing nicely, and quietly!

[thinkbig?] 01/8/2016 16:37

Plenty of dumping today over million at 6.5p get average 9p not bad days work

[thinkbig?] 01/8/2016 11:35

Well that was short lived lol

[ewads] 30/7/2016 09:24

Interesting views given yesterday on BBC's 'A point of view' by Tom Shakespeare who was born with achondroplasia, on what should be considered if/when NIPT is unleashed by the NHS.

[hamidahamida] 28/7/2016 18:14

The Game changer is when the NHS starts offering NIPT tests for free. Announcement can happen any time and this would through all the old forecasts out of the window.

[hamidahamida] 28/7/2016 18:13

The Revenue exit run rate for 2016 was £3.2 million and they put on £2 million of that annualised sales in just the last 6 months of year ended 31/03/2016 and this is the base case for sales for current year ending 31 March 2017 but broker expects far greater take on rate for current year ending March 31 2017 at £9 million If Premaitha hits these number then by spring of next year it will be cash neutral which leads onto the year ending 31 March 2018 when Panmure goes for sales of £15 million and sees a profit of £600,000. There are no broker forecast for 2019 but from 2018 exit run rate sales of £22 + million and a profit of £4/5 million achievable with rapid growth.

[gooosed] 28/7/2016 09:36

Looked on twitter - nothing that I can see, although some prize plum on LSE BB seems to be shoveling large amounts of manure to that effect.

What ever is going on - if it helps push Henderson to divest the last of their 6.5p placing then that's a good thing - imho.

[timojelly] 28/7/2016 09:14

What's going on? Just a bounce? Anything on twitter?

[kaka47] 27/7/2016 20:33

3 blue days interesting

[accrillium] 27/7/2016 18:58

Daily, youre running out of trading days for your 6p. good call. I think I'll follow you for more pearls.

[ramas] 27/7/2016 18:57

Volumes maybe starting to tell a story ....

[thinkbig?] 27/7/2016 17:25

Where you been hiding Ahmid looks like you bought back in